These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21197536)

  • 21. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy.
    Li W; Li H; Long Y
    Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
    Mujkanovic J; Qayyum AA
    Curr Cardiol Rev; 2023; 19(2):e230822207933. PubMed ID: 36017853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.
    Blauwet LA; Libhaber E; Forster O; Tibazarwa K; Mebazaa A; Hilfiker-Kleiner D; Sliwa K
    Heart; 2013 Mar; 99(5):308-13. PubMed ID: 23118348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
    Lehtonen L
    Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?
    Angadi U; Westrope C; Chowdhry MF
    Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):710-4. PubMed ID: 23832921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
    Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
    Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.
    Goland S; Bitar F; Modi K; Safirstein J; Ro A; Mirocha J; Khatri N; Elkayam U
    J Card Fail; 2011 May; 17(5):426-30. PubMed ID: 21549301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting poor left ventricular function recovery in Peripartum cardiomyopathy.
    Prameswari HS; Iswandi CP; Hasan M; Martanto E; Putra ICS; Kamarullah W; Dewi TI; Akbar MR
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279018. PubMed ID: 37935592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Levosimendan in the Treatment of Patients With Severe Septic Cardiomyopathy.
    Sun T; Zhang N; Cui N; Wang SH; Ding XX; Li N; Chen N; Yu ZB
    J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):344-349. PubMed ID: 36473763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).
    McNamara DM; Elkayam U; Alharethi R; Damp J; Hsich E; Ewald G; Modi K; Alexis JD; Ramani GV; Semigran MJ; Haythe J; Markham DW; Marek J; Gorcsan J; Wu WC; Lin Y; Halder I; Pisarcik J; Cooper LT; Fett JD;
    J Am Coll Cardiol; 2015 Aug; 66(8):905-14. PubMed ID: 26293760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
    Lehtonen L
    Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
    Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
    Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT
    Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D; Palit F; Simsek E; Bilgehan K; Sacide A
    Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy.
    Yaman M; Arslan U; Kaya A; Akyol A; Ozturk F; Okudan YE; Bayramoglu A; Bektas O
    Cardiol J; 2016; 23(6):610-615. PubMed ID: 27910084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use.
    Pillarisetti J; Kondur A; Alani A; Reddy M; Reddy M; Vacek J; Weiner CP; Ellerbeck E; Schreiber T; Lakkireddy D
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2831-9. PubMed ID: 24814494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and echocardiographic predictors of outcomes in patients with peripartum cardiomyopathy: A single centre, six month follow-up study.
    Ravi Kiran G; RajKumar C; Chandrasekhar P
    Indian Heart J; 2021; 73(3):319-324. PubMed ID: 34154749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of beta-blockade on the hemodynamic effects of levosimendan in elderly (>or= 70 years) patients with acutely decompensated systolic heart failure.
    Kirlidis TT; Skoularigis J; Tsaknakis KT; Karayiannis G; Tsaknakis TK; Triposkiadis F
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):454-9. PubMed ID: 19640352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
    Meng JB; Hu MH; Lai ZZ; Ji CL; Xu XJ; Zhang G; Tian S
    Med Sci Monit; 2016 May; 22():1486-96. PubMed ID: 27138236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.